Gene · 843
Papers2,703
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,703
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pinostrobin, a fingerroot compound, regulates miR-181b-5p and induces acute leukemic cell apoptosis. | Sci Rep | 2023 | 37208425 | PubTator, text mining | PubMed |
| Bufalin suppresses esophageal squamous cell carcinoma progression by activating the PIAS3/STAT3 signaling pathway. | J Thorac Dis | 2023 | 37197494 | PubTator, text mining | PubMed |
| Genes and Microbiota Interaction in Monogenic Autoimmune Disorders. | Biomedicines | 2023 | 37189745 | PubTator, text mining | PubMed |
| The hyperinflammatory spectrum: from defects in cytotoxicity to cytokine control. | Front Immunol | 2023 | 37187762 | PubTator, text mining | PubMed |
| The critical role of apoptosis in mesenchymal stromal cell therapeutics and implications in homeostasis and normal tissue repair. | Cell Mol Immunol | 2023 | 37185486 | PubTator, text mining | PubMed |
| Making a good egg: human oocyte health, aging, and in vitro development. | Physiol Rev | 2023 | 37171807 | PubTator, text mining | PubMed |
| A Newly Identified Spike Protein Targeted Linear B-Cell Epitope Based Dissolvable Microneedle Array Successfully Eliciting Neutralizing Activities against SARS-CoV-2 Wild-Type Strain in Mice. | Adv Sci (Weinh) | 2023 | 37162232 | PubTator, text mining | PubMed |
| Adenylate kinase 2 is a biomarker related to the prognosis of glioma and the immune microenvironment. | J Clin Lab Anal | 2023 | 37161605 | PubTator, text mining | PubMed |
| Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy. | Cancer Biol Med | 2023 | 37144561 | PubTator, text mining | PubMed |
| Bisphenol A release from commercially available 3-dimensionally printed resins and human cell apoptosis to bisphenol A: an in-vitro study. | J Clin Pediatr Dent | 2023 | 37143426 | PubTator, text mining | PubMed |
| DEPICTER2: a comprehensive webserver for intrinsic disorder and disorder function prediction. | Nucleic Acids Res | 2023 | 37140058 | PubTator, text mining | PubMed |
| ADOPT: intrinsic protein disorder prediction through deep bidirectional transformers. | NAR Genom Bioinform | 2023 | 37138579 | PubTator, text mining | PubMed |
| Community detection in Epstein-Barr virus associated carcinomas and role of tyrosine kinase in etiological mechanisms for oncogenesis. | Microb Pathog | 2023 | 37137346 | PubTator, text mining | PubMed |
| The expanding role of IAP antagonists for the treatment of head and neck cancer. | Cancer Med | 2023 | 37132167 | PubTator, text mining | PubMed |
| Chemical Characterization and Biological Evaluation of Epilobium parviflorum Extracts in an In Vitro Model of Human Malignant Melanoma. | Plants (Basel) | 2023 | 37111814 | PubTator, text mining | PubMed |
| TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy. | Blood Adv | 2023 | 37083684 | PubTator, text mining | PubMed |
| Case report: Synergistic defects of CASP10 and BTK leading to autoimmune lymphoproliferative syndrome type IIa, complicated by severe hemophagocytic lymphohistiocytosis. | Immunol Res | 2023 | 37067653 | PubTator, text mining | PubMed |
| Nano-TRAIL: a promising path to cancer therapy. | Cancer Drug Resist | 2023 | 37065863 | PubTator, text mining | PubMed |
| Autophagy: A Potential Therapeutic Target to Tackle Drug Resistance in Multiple Myeloma. | Int J Mol Sci | 2023 | 37046991 | PubTator, text mining | PubMed |
| Chemical and genomic characterization of a potential probiotic treatment for stony coral tissue loss disease. | Commun Biol | 2023 | 37024599 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/843/papers?page=9